Abstract, Snapshot, Market Analysis & Market Definition: Sickle Cell Anemia Therapeutics Market
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). The classification of Sickle Cell Anemia Therapeutics includes Blood Transfusion, Pharmacotherapy and Bone Marrow Transplant, and the proportion of Blood Transfusion in 2017 is about 45%, and the proportion of Bone Marrow Transplant in 2017 is about 35%. In 2018, the global Sickle Cell Anemia Therapeutics market size was 2408.9 million US$ and it is expected to reach 4998 million US$ by the end of 2025, with a CAGR of 11.0% during 2019-2025. This report focuses on the global Sickle Cell Anemia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sickle Cell Anemia Therapeutics development in United States, Europe and China.
Market Segmentation, Outlook & Regional Insights: Sickle Cell Anemia Therapeutics Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Segmentation by Application : Breakdown of data from year 2014 to 2019 and forecast until 2025:
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Key Players, Recent Developments & Sector Viewpoints: Sickle Cell Anemia Therapeutics Market
BioMarin
Bluebird Bio
DeuteRx
Emmaus Medical
Gamida Cell
Global Blood Therapeutics
GlycoMimetics
Modus Therapeutics
Pfizer
Sancilio Pharmaceuticals
Sangamo Biosciences
Key Insights Covered: Exhaustive Sickle Cell Anemia Therapeutics Market
1. Market size (sales, revenue and growth rate) of Sickle Cell Anemia Therapeutics industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Sickle Cell Anemia Therapeutics industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Sickle Cell Anemia Therapeutics industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Sickle Cell Anemia Therapeutics industry.
Research Methodology: Sickle Cell Anemia Therapeutics Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.